Common Stock, Shares, Outstanding of SANGAMO THERAPEUTICS, INC from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
SANGAMO THERAPEUTICS, INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • SANGAMO THERAPEUTICS, INC Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2024 was 212,837,679, a 19% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

SANGAMO THERAPEUTICS, INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 212,837,679 +34,704,131 +19% 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q4 2023 178,133,548 +11,340,228 +6.8% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q4 2022 166,793,320 +20,871,790 +14% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q4 2021 145,921,530 +3,858,327 +2.7% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q4 2020 142,063,203 +26,090,495 +22% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 115,972,708 +13,785,237 +13% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q4 2018 102,187,471 +16,588,937 +19% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 101,839,668 +17,734,877 +21% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 101,623,521 +18,143,982 +22% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 87,041,208 +15,288,795 +21% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 85,598,534 +14,726,632 +21% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 84,104,791 +13,482,954 +19% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 83,479,539 +12,873,276 +18% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 71,752,413 +1,352,377 +1.9% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 70,871,902 +517,294 +0.74% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 70,621,837 +579,079 +0.83% 30 Sep 2016 10-Q 27 Oct 2016 2016 Q3
Q2 2016 70,606,263 +803,566 +1.2% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 70,400,036 +902,780 +1.3% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 70,354,608 +1,292,214 +1.9% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 70,042,758 +1,709,485 +2.5% 30 Sep 2015 10-Q 30 Oct 2015 2015 Q3
Q2 2015 69,802,697 +1,701,218 +2.5% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 69,497,256 +1,674,954 +2.5% 31 Mar 2015 10-Q 28 Apr 2015 2015 Q1
Q4 2014 69,062,394 +6,818,502 +11% 31 Dec 2014 10-K 18 Feb 2016 2015 FY
Q3 2014 68,333,273 +6,912,618 +11% 30 Sep 2014 10-Q 28 Oct 2014 2014 Q3
Q2 2014 68,101,479 +14,127,027 +26% 30 Jun 2014 10-Q 29 Jul 2014 2014 Q2
Q1 2014 67,822,302 +14,275,986 +27% 31 Mar 2014 10-Q 07 May 2014 2014 Q1
Q4 2013 62,243,892 +9,185,367 +17% 31 Dec 2013 10-K 25 Feb 2015 2014 FY
Q3 2013 61,420,655 +8,556,984 +16% 30 Sep 2013 10-Q 04 Nov 2013 2013 Q3
Q2 2013 53,974,452 +1,419,657 +2.7% 30 Jun 2013 10-Q 02 Aug 2013 2013 Q2
Q1 2013 53,546,316 +959,726 +1.8% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 53,058,525 +503,730 +0.96% 31 Dec 2012 10-K 24 Feb 2014 2013 FY
Q3 2012 52,863,671 +391,739 +0.75% 30 Sep 2012 10-Q 02 Nov 2012 2012 Q3
Q2 2012 52,554,795 +110,338 +0.21% 30 Jun 2012 10-Q 03 Aug 2012 2012 Q2
Q1 2012 52,586,590 31 Mar 2012 10-Q 07 May 2012 2012 Q1
Q4 2011 52,554,795 +7,177,056 +16% 31 Dec 2011 10-K 26 Feb 2013 2012 FY
Q3 2011 52,471,932 30 Sep 2011 10-Q 04 Nov 2011 2011 Q3
Q2 2011 52,444,457 30 Jun 2011 10-Q 05 Aug 2011 2011 Q2
Q4 2010 45,377,739 31 Dec 2010 10-K 23 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.